IART Form 4: 11,965 RSUs vested; direct ownership now 21,936

Q: What did IART disclose in this Form 4?

An officer reported the vesting of 11,965 RSUs on 10/12/2025 and related share withholding for taxes.

Q: Who is the reporting person and role at IART?

Harvinder Singh, EVP & President, International .

Q: How many shares were withheld for taxes and at what price?

3,281 shares were withheld at $13.34 per share.

Q: How many shares did the officer retain from the vesting?

The officer retained 8,684 shares issued upon RSU vesting.

Q: What is the officer’s direct beneficial ownership after the transactions?

Direct beneficial ownership is 21,936 common shares.

Q: When did the RSU award vest and what was the grant date?

It vested in full on 10/12/2025 , the third anniversary of the 10/12/2022 grant.

Filing Impact

(Neutral)

Filing Sentiment

(Negative)

Form Type

Rhea-AI Filing Summary

Integra LifeSciences (IART) reported an insider equity event. EVP & President, International Harvinder Singh vested 11,965 restricted stock units on 10/12/2025, which settled into common stock. To cover taxes, 3,281 shares were withheld at $13.34, and the reporting person retained 8,684 shares from the vesting. Following these transactions, direct beneficial ownership stood at 21,936 common shares.

The RSU award vested in full on the third anniversary of its grant date (10/12/2022). Derivative securities beneficially owned following the event were 22,566 RSUs.

Insider Trade Summary

11,965 shares exercised/converted

Mixed 3 txns

Insider Singh Harvinder

Role EVP & PRESIDENT, INTERNATIONAL

Type	Security	Shares	Price	Value
Exercise	Restricted Stock Units	11,965	$0.00	--
Exercise	Common Stock	11,965	$0.00	--
Tax Withholding	Common Stock	3,281	$13.34	$44K

Holdings After Transaction: Restricted Stock Units — 22,566 shares (Direct); Common Stock — 25,217 shares (Direct)

Footnotes (1)

Represents shares withheld to satisfy the reporting person's tax withholding obligation with respect to 11,965 shares of common stock issued upon the vesting of time based restricted stock units on October 12, 2025. The reporting person retained the remaining 8,684 shares. The award was a restricted stock unit award which vested in full on the third anniversary of the grant date of 10/12/2022.

Form 4 Insider Transactions: What Each Field Means →

10/14/2025 - 04:28 PM

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

1. Name and Address of Reporting Person^*

Singh Harvinder

(Last)

(First)

(Middle)

1100 CAMPUS ROAD

(Street)

PRINCETON

08540

(City)

(State)

(Zip)

2. Issuer Name and Ticker or Trading Symbol
INTEGRA LIFESCIENCES HOLDINGS CORP [ IART ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	EVP & PRESIDENT, INTERNATIONAL

3. Date of Earliest Transaction (Month/Day/Year)
10/12/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	10/12/2025		M		11,965	A	$0	25,217	D
Common Stock	10/12/2025		F		3,281⁽¹⁾	D	$13.34	21,936	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
Restricted Stock Units	$0	10/12/2025		M			11,965	⁽²⁾	⁽²⁾	Common Stock	11,965	$0	22,566	D

Explanation of Responses:

1. Represents shares withheld to satisfy the reporting person's tax withholding obligation with respect to 11,965 shares of common stock issued upon the vesting of time based restricted stock units on October 12, 2025. The reporting person retained the remaining 8,684 shares.

2. The award was a restricted stock unit award which vested in full on the third anniversary of the grant date of 10/12/2022.

Remarks:

	/s/ Lesha Shinn; Attorney-in-Fact for Harvinder Singh	10/14/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Source: View Original Filing on SEC EDGAR

FAQ

What did IART disclose in this Form 4?

An officer reported the vesting of 11,965 RSUs on 10/12/2025 and related share withholding for taxes.

Who is the reporting person and role at IART?

Harvinder Singh, EVP & President, International.

How many shares were withheld for taxes and at what price?

3,281 shares were withheld at $13.34 per share.

How many shares did the officer retain from the vesting?

The officer retained 8,684 shares issued upon RSU vesting.

What is the officer’s direct beneficial ownership after the transactions?

Direct beneficial ownership is 21,936 common shares.

When did the RSU award vest and what was the grant date?

It vested in full on 10/12/2025, the third anniversary of the 10/12/2022 grant.

How many derivative securities (RSUs) remain beneficially owned?

Derivative securities beneficially owned following the transactions total 22,566 RSUs.